J M Glendening

Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

Michael P. Vitek, Koushik Bhattacharya, J M Glendening et al. · Proceedings of the National Academy of Sciences · 1994 · 795 citations · Full text

Glycobiology, Alzheimer's Disease, Bioanalysis +17

Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression.

J A Reed, Frank Loganzo, C R Shea et al. · PubMed · 1995 · 261 citations

Invasive Stage, Cell Signaling, Cell Cycle Control +14

Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.

Mark L. Gonzalgo, Christina M. Bender, Edward You et al. · PubMed · 1997 · 131 citations

Epigenetic Change, Genetics, Dna Methylation +22

PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines

Pamela M. Pollock, Graeme J. Walker, J M Glendening et al. · Melanoma Research · 2002 · 72 citations

Melanoma Cell Lines, Gene Deletion Data, Medicine +14

Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.

J M Glendening, J F Flores, Graeme J. Walker et al. · PubMed · 1995 · 57 citations

Genetics, Pathology, Tumor Biology +16